Revolutionizing Depression Treatment: ABVC BioPharma's Botanical Antidepressant
01:59 Share

Dr. Uttam Patil, CEO of ABVC BioPharma, is driving innovation with ABV-1504, a botanical antidepressant candidate free from suicidal ideation side effects. The company aims to dominate the global markets for Major Depressive Disorder and ADHD treatments, as well as the botanical drug market, with a robust drug pipeline and strategic partnerships.